Felipe Couñago, Medical Director at GenesisCare Spain, shared a post on LinkedIn:
“New real-world evidence from Spain on stage III NSCLC!
A national GOECP-SEOR study has analyzed 1,505 patients from 35 radiation oncology departments, confirming the strong impact of concurrent chemoradiotherapy (cCRT) followed by durvalumab in routine clinical practice.
Key highlights:
- Durvalumab more than doubled OS after cCRT (44 vs 19 months).
- Significant improvements in PFS, even after multivariate adjustment.
- Extensive use of IMRT/VMAT and IGRT, reflecting high-quality radiotherapy nationwide.
- Toxicity remained manageable, with low rates of ≥G3 pneumonitis.
These data reinforce how real-world practice in Spain aligns with international standards and the PACIFIC paradigm, while also highlighting remaining challenges in accessibility and treatment optimization.
Huge congratulations to GOECP-SEOR and all authors for delivering such a valuable and impactful contribution to our field.
An excellent step forward for patients and for the thoracic oncology community!”
Title: Stage III NSCLC Treatment Patterns in Spain: A Population-Based Study of the GOECP-SEOR
Authors: Paloma Sosa-Fajardo, Margarita Martín-Martín, Javier Luna-Tirado, José Luis López-Guerra, Elías Gomis-Sellés, Miriam López-Mata, Germán Valtueña-Peydró, Marina Santos-Rodríguez, Ana-María Álvarez-González, Guillermo Potdevin-Stein, Paula Martín-Barrientos, Andrea Kannemann, Nuria Farré-Bernadó, Elisabet González-Portillo, Aurea Manso-Lema, Marta Rodríguez-Roldán, María-Ángeles González-Ruiz, Amadeo Wals-Zurita, Nuria-Azahara Linares-Mesa, Sara Garduño-Sánchez, Patricia Barrionuevo-Castillo, Beatriz Moreno-Fuentes, Maximiliano Martos-Alcalde, Paula Simón-Silva, Mariana-Teresa Peña-Perea, Manuel-Luis Blanco-Villar, Victoria Vera-Barragán, Abrahams Ocanto-Martínez, María Mateos-Domínguez, Carmen Vallejo-Ocaña, Raúl Hernanz-Lucas, José-Enrique Castro-Gómez, Marina Peña-Huertas, Víctor Duque-Santana, José Zapatero-Ortuño, Celia García-Torres, Patricia Valencia-Nieto, Patricia Diezhandino-García, Clara Eito-Valdovinos, Alicia Olarte-García, Luis-Leonardo Guerrero-Gómez, Sofía Sánchez-García, Andrea Bobo-Jaureguizar, Amalia Sotoca-Ruiz, Beatriz Vázquez-Barreiro, Guillermo Cameselle-Gallego, Sonia Flamarique-Andueza, Mikel Rico-Oses, Marcos Guijarro-Verdu, Miguel Montijano-Linde, Laura Guzmán-Gómez, Ana-Belén Bezares-Alarcón, Cristina Cigarral-García, Paloma Moreno-Ceano, Javier Serrano-Andreu, Mauricio Murcia-Mejía, María Pagola-Divassón, Francesc Casas-Duran, Piedad Almendros-Blanco, Sara Pedraza-Fernández, José-Antonio González-Ferreira, Pino Alcántara
You can read the full article in MDPI Cancers.
More posts featuring Felipe Couñago.